Modelling the opportunity for cost-savings or patient access with biosimilar adalimumab and tocilizumab: a European perspective.
Article in Journal of Medical Economics (July 2024)
The most recent citing publications are shown below. View all 57 publications that cite this research output on Dimensions.
Article in Journal of Medical Economics (July 2024)
Article in BioDrugs (June 2024)
Article in Advances in Therapy (March 2024)